Panel Detail
Tuesday, November 8, 2011
10:15 AM - 10:40 AM
Presentation - Multiple Myeloma Research Foundation, Personalized Medicine Initiative
The MMRF Personalized Medicine Initiative will establish a
community of newly diagnosed patients in a longitudinal study (LS)
and a data ecosystem to accelerate development of new, targeted
treatment regimens. The LS is a core element of the MMRF's
personalized medicine pogram with the goal of segmenting
patients based on molecular profiling leading toward tailored
therapies for specific subgroups. The LS study called CoMMpass
will enroll a minimum of 1,000 newly diagnosed patients. Both
clinical data and molecular profiling data will be collected upon
diagnosis/enrollment, and continuously thereafter prior to/upon
any changes to therapy as well as at disease progression.
Presenters
Walter Capone, COO, Multiple Myeloma Research Foundation
Adrian McKemey, Managing Director, Quintiles
| 
